Daiichi Sankyo Nordics ApS
Private limited companyCVR 39371049København SActive
Daiichi Sankyo Nordics ApS is a private limited company, based in København S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2018. Net profit rose 91% from 2025 to 2026, ending at DKK 17.3m. Profit has grown three years in a row. With 32 employees, the company is about 4 times larger than the industry median.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- Gross profit rose 20% (2025 → 2026), to DKK 83.6m.
- Net profit rose 91% (2025 → 2026), to DKK 17.3m.
- Equity rose 75% (2025 → 2026), to DKK 40.3m.
Management and owners, last 24 months
- New in management: Christophe Tiberghien (director, 01/02/2026) and Christophe Tiberghien (board member, 01/02/2026).
- Stepped down: Åke Magnus Gisel (director, 01/02/2026) and Åke Magnus Gisel (board member, 01/02/2026).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 27,407 | 35,621 | 47,833 | 57,381 | 69,482 | 83,559 | +20.3% |
| Operating profit (EBIT) | 1,156 | 292 | – | 15,174 | 13,405 | 23,848 | +77.9% |
| Profit before tax | 1,115 | −50 | 2,726 | 11,709 | 12,103 | 22,341 | +84.6% |
| Net profit | 846 | 46 | 2,350 | 8,449 | 9,021 | 17,269 | +91.4% |
| Total assets | 19,755 | 48,945 | 106,680 | 181,342 | 261,484 | 313,234 | +19.8% |
| Equity | 3,337 | 3,383 | 5,733 | 14,056 | 23,077 | 40,346 | +74.8% |
| Liabilities | 16,418 | 45,562 | – | – | 238,407 | 272,887 | +14.5% |
| Cash and cash equivalents | 5,767 | 11,607 | 24,372 | – | 28,401 | 98,516 | +246.9% |
| Average number of employees | 16 | 22 | 24 | 26 | 38 | 41 | +7.9% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2026 figuresProfit for five years in a row
Net result has been positive in 2022–2026.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/04/2025 – 31/03/2026 | 14/10/2026 | The company | PDF not statedXBRL |
| 2025 | 01/04/2024 – 31/03/2025 | 03/10/2025 | The company | PDF not statedXBRL |
| 2024 | 01/04/2023 – 31/03/2024 | 16/10/2024 | The company | PDF not statedXBRL |
| 2023 | 01/04/2022 – 31/03/2023 | 02/10/2023 | The company | PDF not statedXBRL |
| 2022 | 01/04/2021 – 31/03/2022 | 30/09/2022 | The company | PDFXBRL |
| 2021 | 01/04/2020 – 31/03/2021 | 15/09/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 182of 9,892 Better than 98% | No. 884of 9,922 Better than 91% |
| Same industry and 20–49 employees47 companies in the comparison | No. 4of 47 Better than 93% | No. 23of 47 Better than 52% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 398of 33,588 Better than 99% | No. 1,400of 33,687 Better than 96% |
| All companies of type ApS66,508 companies in the comparison | No. 376of 66,379 Better than 99% | No. 2,501of 66,505 Better than 96% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Daiichi Sankyo Nordics ApSDKK 83.6m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Daiichi Sankyo Nordics ApSDKK 17.3m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Daiichi Sankyo Nordics ApSDKK 40.3m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Daiichi Sankyo Nordics ApS32
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Daiichi Sankyo Oncology Europe GmbH100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Christophe Tiberghien | Director | 01/02/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Karin Margaretha Heisterberg | Board member | 03/08/2022 |
| Jacob Wessel-Tolvig | Board member | 19/01/2023 |
| Christophe Tiberghien | Board member | 01/02/2026 |
- Auditor
- KPMG P/S
- Founders
- Ulrik Fleischer-Michaelsen
Former management (9)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Patrik Josef Grandits | CEO | 28/02/2018 | 31/05/2020 |
| Stefan Gerd Koch | Board member | 11/09/2019 | 19/01/2023 |
| Patrik Josef Mag. Grandits | Chair of the board | 11/09/2019 | 31/05/2020 |
| Stefan Gerd Koch | Board member | 11/09/2019 | 11/09/2019 |
| Tim Ellmers | Board member | 11/09/2019 | 03/08/2022 |
| Nicola Torosantucci | Director | 01/06/2020 | 31/07/2020 |
| Nicola Torosantucci | Board member | 01/06/2020 | 31/07/2020 |
| Åke Magnus Gisel | Director | 01/08/2020 | 01/02/2026 |
| Åke Magnus Gisel | Board member | 01/08/2020 | 01/02/2026 |
Signing rule: Selskabet tegnes af direktionen eller af den samlede bestyrelse.
Address and production units
1 active production unitsAmagerfælledvej 106
2300 København S
København Municipality · Postcode 2300
Other companies at the address (4)
- Karo Healthcare ApSWholesale of pharmaceutical goods and nursing supplies
- Smartbox Group Denmark A/SOther business support service activities n.e.c.
- Fischer & Kerrn A/SComputer programming activities
- TrueStory ApSOther information technology and computer service activities
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Daiichi Sankyo Nordics ApS | Amagerfælledvej 106, 2, 2300 København S | 30 | 1023390333 |
Purpose
Selskabets formål er forskning og udvikling, handel, markedsføring og distribution, import og eksport, licenssøgning samt lignende aktiviteter inden for farmaceutiske, kemiske, biokemiske, medicinske og veterinærmedicinske, biologiske, hygieniske, kosmetiske og lignende produkter og apparater, herunder medicinske hjælpemidler.
The purpose is quoted from the register in Danish.
Changes year by year
33 registered events20265 changesaccounts 1 · management 4
- AccountsAnnual report for 2026 published
- ManagementChristophe Tiberghien appointed director
- ManagementChristophe Tiberghien appointed board member
- ManagementÅke Magnus Gisel stepped down as board member
- ManagementÅke Magnus Gisel stepped down as director
20251 changeaccounts 1
- AccountsAnnual report for 2025 published
20241 changeaccounts 1
- AccountsAnnual report for 2024 published
20234 changesaddress 1 · accounts 1 · management 2
- AddressMoved to Amagerfælledvej 106, 2, 2300 København S
- AccountsAnnual report for 2023 published
- ManagementJacob Wessel-Tolvig appointed board member
- ManagementStefan Gerd Koch stepped down as board member
20223 changesaccounts 1 · management 2
- AccountsAnnual report for 2022 published
- ManagementKarin Margaretha Heisterberg appointed board member
- ManagementTim Ellmers stepped down as board member
20212 changesaccounts 1 · address 1
- AccountsAnnual report for 2021 published
- AddressMoved to Amagerfælledvej 106, 2, 2300 København S
20208 changesmanagement 8
- ManagementÅke Magnus Gisel appointed board member
- ManagementÅke Magnus Gisel appointed director
- ManagementNicola Torosantucci stepped down as board member
- ManagementNicola Torosantucci stepped down as director
- ManagementNicola Torosantucci appointed board member
- ManagementNicola Torosantucci appointed director
- ManagementPatrik Josef Mag. Grandits stepped down as chair of the board
- ManagementPatrik Josef Grandits stepped down as ceo
20195 changesname 1 · management 4
- NameName changed from Daiichi Sankyo Oncology Nordics ApS to Daiichi Sankyo Nordics ApS
- ManagementTim Ellmers appointed board member
- ManagementStefan Gerd Koch appointed board member
- ManagementStefan Gerd Koch stepped down as board member
- ManagementPatrik Josef Mag. Grandits appointed chair of the board
20184 changescapital 1 · founded 1 · management 1 · ownership 1
- CapitalShare capital changed from 50,000 DKK to 100,000 DKK
- FoundedRegistered as Daiichi Sankyo Oncology Nordics ApS
- ManagementPatrik Josef Grandits appointed ceo
- OwnershipDaiichi Sankyo Oncology Europe GmbH registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Same people in management
- Chr. Hansen A/Svia Karin Margaretha Heisterberg
- Tesla Motors Denmark ApSvia Ulrik Fleischer-Michaelsen
- Hcl Technologies Denmark ApSvia Ulrik Fleischer-Michaelsen
- BenBau ApSvia Ulrik Fleischer-Michaelsen
- Foundever Denmark ApSvia Ulrik Fleischer-Michaelsen
- Bird & Bird Advokatpartnerselskabvia Ulrik Fleischer-Michaelsen
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.